{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:45:44Z","timestamp":1790034344131,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T00:00:00Z","timestamp":1415318400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s10822-014-9811-6","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T19:16:14Z","timestamp":1415992574000},"page":"155-163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Identification of antipsychotic drug fluspirilene as a potential p53-MDM2 inhibitor: a combined computational and experimental study"],"prefix":"10.1007","volume":"29","author":[{"given":"Sachin P.","family":"Patil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Pacitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S.","family":"Gilroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Butera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Notarfrancesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Stoddart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,7]]},"reference":[{"issue":"17","key":"9811_CR1","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1038\/sj.onc.1208615","volume":"24","author":"SL Harris","year":"2005","unstructured":"Harris SL, Levine AJ (2005) The p53 pathway: positive and negative feedback loops. Oncogene 24(17):2899\u20132908","journal-title":"Oncogene"},{"issue":"12","key":"9811_CR2","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nrc2012","volume":"6","author":"F Toledo","year":"2006","unstructured":"Toledo F, Wahl GM (2006) Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 6(12):909\u2013923","journal-title":"Nat Rev Cancer"},{"issue":"14","key":"9811_CR3","first-page":"1001","volume":"1","author":"UM Moll","year":"2003","unstructured":"Moll UM, Petrenko O (2003) The MDM2-p53 interaction. Mol Cancer Res MCR 1(14):1001\u20131008","journal-title":"Mol Cancer Res MCR"},{"issue":"5289","key":"9811_CR4","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1126\/science.274.5289.948","volume":"274","author":"PH Kussie","year":"1996","unstructured":"Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, Pavletich NP (1996) Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274(5289):948\u2013953","journal-title":"Science"},{"issue":"2","key":"9811_CR5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrc991","volume":"3","author":"P Chene","year":"2003","unstructured":"Chene P (2003) Inhibiting the p53-MDM2 interaction: an important target for cancer therapy. Nat Rev Cancer 3(2):102\u2013109","journal-title":"Nat Rev Cancer"},{"issue":"5659","key":"9811_CR6","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","volume":"303","author":"LT Vassilev","year":"2004","unstructured":"Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, Fotouhi N, Liu EA (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303(5659):844\u2013848","journal-title":"Science"},{"issue":"6","key":"9811_CR7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2174\/138161211795222577","volume":"17","author":"C Zhan","year":"2011","unstructured":"Zhan C, Lu W (2011) Peptide activators of the p53 tumor suppressor. Curr Pharm Des 17(6):603\u2013609","journal-title":"Curr Pharm Des"},{"issue":"7172","key":"9811_CR8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nature06526","volume":"450","author":"JA Wells","year":"2007","unstructured":"Wells JA, McClendon CL (2007) Reaching for high-hanging fruit in drug discovery at protein\u2013protein interfaces. Nature 450(7172):1001\u20131009","journal-title":"Nature"},{"issue":"4","key":"9811_CR9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/jm049137g","volume":"48","author":"BL Grasberger","year":"2005","unstructured":"Grasberger BL, Lu T, Schubert C, Parks DJ, Carver TE, Koblish HK, Cummings MD, LaFrance LV, Milkiewicz KL, Calvo RR, Maguire D, Lattanze J, Franks CF, Zhao S, Ramachandren K, Bylebyl GR, Zhang M, Manthey CL, Petrella EC, Pantoliano MW, Deckman IC, Spurlino JC, Maroney AC, Tomczuk BE, Molloy CJ, Bone RF (2005) Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells. J Med Chem 48(4):909\u2013912","journal-title":"J Med Chem"},{"issue":"10","key":"9811_CR10","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1073\/pnas.0708917105","volume":"105","author":"S Shangary","year":"2008","unstructured":"Shangary S, Qin D, McEachern D, Liu M, Miller RS, Qiu S, Nikolovska-Coleska Z, Ding K, Wang G, Chen J, Bernard D, Zhang J, Lu Y, Gu Q, Shah RB, Pienta KJ, Ling X, Kang S, Guo M, Sun Y, Yang D, Wang S (2008) Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition. Proc Natl Acad Sci USA 105(10):3933\u20133938","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"9811_CR11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1747-0285.2012.01428.x","volume":"80","author":"WA Warner","year":"2012","unstructured":"Warner WA, Sanchez R, Dawoodian A, Li E, Momand J (2012) Identification of FDA-approved drugs that computationally bind to MDM2. Chem Biol Drug Des 80(4):631\u2013637","journal-title":"Chem Biol Drug Des"},{"issue":"1","key":"9811_CR12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"JJ Irwin","year":"2005","unstructured":"Irwin JJ, Shoichet BK (2005) ZINC\u2013a free database of commercially available compounds for virtual screening. J Chem Inf Model 45(1):177\u2013182","journal-title":"J Chem Inf Model"},{"issue":"1","key":"9811_CR13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28(1):235\u2013242","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"9811_CR14","first-page":"57","volume":"17","author":"MF Sanner","year":"1999","unstructured":"Sanner MF (1999) Python: a programming language for software integration and development. J Mol Graph Model 17(1):57\u201361","journal-title":"J Mol Graph Model"},{"issue":"16","key":"9811_CR15","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30(16):2785\u20132791","journal-title":"J Comput Chem"},{"issue":"2","key":"9811_CR16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461","journal-title":"J Comput Chem"},{"issue":"6","key":"9811_CR17","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.4161\/cc.9.6.10956","volume":"9","author":"GM Popowicz","year":"2010","unstructured":"Popowicz GM, Czarna A, Wolf S, Wang K, Wang W, Domling A, Holak TA (2010) Structures of low molecular weight inhibitors bound to MDMX and MDM2 reveal new approaches for p53-MDMX\/MDM2 antagonist drug discovery. Cell Cycle 9(6):1104\u20131111","journal-title":"Cell Cycle"},{"issue":"1","key":"9811_CR18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00894-011-1041-4","volume":"18","author":"F Wang","year":"2012","unstructured":"Wang F, Li Y, Ma Z, Wang X, Wang Y (2012) Structural determinants of benzodiazepinedione\/peptide-based p53-HDM2 inhibitors using 3D-QSAR, docking and molecular dynamics. J Mol Model 18(1):295\u2013306","journal-title":"J Mol Model"},{"issue":"16","key":"9811_CR19","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1021\/jm060522a","volume":"49","author":"PD Lyne","year":"2006","unstructured":"Lyne PD, Lamb ML, Saeh JC (2006) Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. J Med Chem 49(16):4805\u20134808","journal-title":"J Med Chem"},{"issue":"12","key":"9811_CR20","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/anie.201003863","volume":"50","author":"GM Popowicz","year":"2011","unstructured":"Popowicz GM, Domling A, Holak TA (2011) The structure-based design of Mdm2\/Mdmx-p53 inhibitors gets serious. Angew Chem 50(12):2680\u20132688","journal-title":"Angew Chem"},{"issue":"2","key":"9811_CR21","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","volume":"49","author":"W Sherman","year":"2006","unstructured":"Sherman W, Day T, Jacobson MP, Friesner RA, Farid R (2006) Novel procedure for modeling ligand\/receptor induced fit effects. J Med Chem 49(2):534\u2013553","journal-title":"J Med Chem"},{"issue":"2","key":"9811_CR22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10822-014-9732-4","volume":"28","author":"SP Patil","year":"2014","unstructured":"Patil SP, Ballester PJ, Kerezsi CR (2014) Prospective virtual screening for novel p53-MDM2 inhibitors using ultrafast shape recognition. J Comput Aided Mol Des 28(2):89\u201397","journal-title":"J Comput Aided Mol Des"},{"issue":"11","key":"9811_CR23","first-page":"1689","volume":"20","author":"PA Janssen","year":"1970","unstructured":"Janssen PA, Niemegeers CJ, Schellekens KH, Lenaerts FM, Verbruggen FJ, van Nueten JM, Marsboom RH, Herin VV, Schaper WK (1970) The pharmacology of fluspirilene (R 6218), a potent, long-acting and injectable neuroleptic drug. Arzneimittelforschung 20(11):1689\u20131698","journal-title":"Arzneimittelforschung"},{"issue":"3","key":"9811_CR24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jmb.2005.05.010","volume":"350","author":"S Uhrinova","year":"2005","unstructured":"Uhrinova S, Uhrin D, Powers H, Watt K, Zheleva D, Fischer P, McInnes C, Barlow PN (2005) Structure of free MDM2 N-terminal domain reveals conformational adjustments that accompany p53-binding. J Mol Biol 350(3):587\u2013598","journal-title":"J Mol Biol"},{"issue":"12","key":"9811_CR25","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.str.2013.09.006","volume":"21","author":"M Bista","year":"2013","unstructured":"Bista M, Wolf S, Khoury K, Kowalska K, Huang Y, Wrona E, Arciniega M, Popowicz GM, Holak TA, Domling A (2013) Transient protein states in designing inhibitors of the MDM2-p53 interaction. Structure\u00a021(12):2143\u20132151","journal-title":"Structure"},{"issue":"3","key":"9811_CR26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.celrep.2013.07.018","volume":"4","author":"A Moghaddas Gholami","year":"2013","unstructured":"Moghaddas Gholami A, Hahne H, Wu Z, Auer FJ, Meng C, Wilhelm M, Kuster B (2013) Global proteome analysis of the NCI-60 cell line panel. Cell Rep 4(3):609\u2013620","journal-title":"Cell Rep"},{"issue":"1","key":"9811_CR27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijc.24813","volume":"126","author":"ED Wiklund","year":"2010","unstructured":"Wiklund ED, Catts VS, Catts SV, Ng TF, Whitaker NJ, Brown AJ, Lutze-Mann LH (2010) Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic target. Int J Cancer J Int Cancer 126(1):28\u201340","journal-title":"Int J Cancer J Int Cancer"},{"issue":"5","key":"9811_CR28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-2007-1017384","volume":"18","author":"P Hassel","year":"1985","unstructured":"Hassel P (1985) Experimental comparison of low doses of 1.5\u00a0mg fluspirilene and bromazepam in out-patients with psychovegetative disturbances. Pharmacopsychiatry 18(5):297\u2013302","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"9811_CR29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0031-6997(25)06839-5","volume":"32","author":"P Seeman","year":"1980","unstructured":"Seeman P (1980) Brain dopamine receptors. Pharmacol Rev 32(3):229\u2013313","journal-title":"Pharmacol Rev"},{"issue":"9","key":"9811_CR30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1185\/03007997709115285","volume":"4","author":"SD Soni","year":"1977","unstructured":"Soni SD (1977) Fluspirilene in the treatment of non-hospitalized schizophrenic patients. Curr Med Res Opin 4(9):645\u2013649","journal-title":"Curr Med Res Opin"},{"key":"9811_CR31","unstructured":"The docking search space coordinates used for Autock Vina screening were: 4HG7 [Center X:-19.750, Y:13.9838, Z:-8.2689; Dimensions (\u00c5) X:34.1653, Y:39.7419, Z:29.5033], 1RV1 [Center X:13.5799, Y:0.8461, Z:19.5511; Dimensions (\u00c5) X:44.1592, Y:34.3006, Z:28.3009], 3LBL [Center X:-28.9098, Y:17.4573, Z:-50.1283; Dimensions (\u00c5) X:38.5244, Y:32.8518, Z:32.6208], and 3LBK [Center X:18.8133, Y:10.8160, Z:4.4580; Dimensions (\u00c5) X:33.6391, Y:34.8912, Z:33.4187]"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-014-9811-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-014-9811-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-014-9811-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:18:24Z","timestamp":1747160304000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-014-9811-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,7]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["9811"],"URL":"https:\/\/doi.org\/10.1007\/s10822-014-9811-6","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,7]]}}}